Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology, P.A. - Bedford
mi
from
Bedford, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
El Paso Cancer Treatment Ctr - East
mi
from
El Paso, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
El Paso Cancer Treatment Ctr - East
mi
from
El Paso, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
South Texas Cancer Center
mi
from
McAllen, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
South Texas Cancer Center
mi
from
McAllen, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Centers of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Highline Medical Oncology
mi
from
Burien, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Highline Medical Oncology
mi
from
Burien, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Pudget Sound Cancer Center
mi
from
Edmonds, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Pudget Sound Cancer Center
mi
from
Edmonds, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Northwest
mi
from
Spokane, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Central Indiana Cancer Centers
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
New York Oncology Hematology PC
mi
from
Albany, NY
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Willamette Valley Cancer Center
mi
from
Springfield, OR
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Willamette Valley Cancer Center
mi
from
Springfield, OR
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Medical Oncology Associates of Wyoming Valley, PC
mi
from
Kingston, PA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Medical Oncology Associates of Wyoming Valley, PC
mi
from
Kingston, PA
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center, Abilene
mi
from
Abilene, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center, Abilene
mi
from
Abilene, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center
mi
from
Arlington, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology - Round Rock Cancer Center
mi
from
Austin, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology - Round Rock Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology, PA
mi
from
Dallas, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology PA
mi
from
Garland, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology PA
mi
from
Garland, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Longview Cancer Center
mi
from
Longview, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Longview Cancer Center
mi
from
Longview, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology - Allison Cancer Center
mi
from
Midland, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology - Allison Cancer Center
mi
from
Midland, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Cancer Care Centers of South Texas-HOAST
mi
from
San Antonio, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Cancer Care Centers of South Texas-HOAST
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Tyler Cancer Center
mi
from
Tyler, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Click here to add this to my saved trials
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated:  2/2/2016
Virginia Oncology Associates
mi
from
Norfolk, VA
Gemzar, Cisp, Sunitinib Urothelial Ca
Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma
Status: Enrolling
Updated: 2/2/2016
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and Dasatinib for Patients With Advanced Solid Tumors With Expanded Cohort of Patients With Previously Untreated Metastatic Colorectal Cancer.
Status: Enrolling
Updated:  2/2/2016
Rocky Mountain Cancer Center
mi
from
Denver, CO
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and Dasatinib for Patients With Advanced Solid Tumors With Expanded Cohort of Patients With Previously Untreated Metastatic Colorectal Cancer.
Status: Enrolling
Updated: 2/2/2016
Rocky Mountain Cancer Center
mi
from
Denver, CO
Click here to add this to my saved trials
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and Dasatinib for Patients With Advanced Solid Tumors With Expanded Cohort of Patients With Previously Untreated Metastatic Colorectal Cancer.
Status: Enrolling
Updated:  2/2/2016
Duke Univeristy Medical Center
mi
from
Durham, NC
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and Dasatinib for Patients With Advanced Solid Tumors With Expanded Cohort of Patients With Previously Untreated Metastatic Colorectal Cancer.
Status: Enrolling
Updated: 2/2/2016
Duke Univeristy Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated:  2/2/2016
Christiana Care Health System
mi
from
Newark, DE
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated: 2/2/2016
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated:  2/2/2016
Cooper Health System
mi
from
Voorhees, NJ
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated: 2/2/2016
Cooper Health System
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated:  2/2/2016
Virtua Health System
mi
from
Voorhees, NJ
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated: 2/2/2016
Virtua Health System
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated:  2/2/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated: 2/2/2016
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated:  2/2/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Couple-Focused Intervention for Breast Cancer Patients
Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Status: Enrolling
Updated: 2/2/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated:  2/2/2016
Dana Farber Cancer Institute (DFCI)
mi
from
Boston, MA
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated: 2/2/2016
Dana Farber Cancer Institute (DFCI)
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated:  2/2/2016
St. Luke's Hospital and Health Network St Luke's
mi
from
Bethlehem, PA
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated: 2/2/2016
St. Luke's Hospital and Health Network St Luke's
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated:  2/2/2016
University of California at Los Angeles UCLA - Santa Monica
mi
from
Los Angeles, CA
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated: 2/2/2016
University of California at Los Angeles UCLA - Santa Monica
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated:  2/2/2016
Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem
mi
from
Rockville, MD
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated: 2/2/2016
Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated:  2/2/2016
Novartis Investigative Site
mi
from
Edmonton,
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy
Status: Enrolling
Updated: 2/2/2016
Novartis Investigative Site
mi
from
Edmonton,
Click here to add this to my saved trials
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety & Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
Status: Enrolling
Updated:  2/2/2016
TESARO Inc
mi
from
Waltham, MA
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety & Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
Status: Enrolling
Updated: 2/2/2016
TESARO Inc
mi
from
Waltham, MA
Click here to add this to my saved trials
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
A Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  2/2/2016
TESARO Inc
mi
from
Waltham, MA
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
A Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 2/2/2016
TESARO Inc
mi
from
Waltham, MA
Click here to add this to my saved trials